UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 65.80
+1.30 (2.02%)
Nov 13, 2026, 1:23 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 4.19 billion as of November 13, 2026. It is the 23,352nd most valuable company in the world and the 1,161st biggest in Taiwan. Its market cap has increased by 3.00% in one year.
Market Cap
4.19B
Enterprise Value
3.54B
Revenue
22.46M
Global Rank
Country Rank
#1,161 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 4.19B, an increase of 142.33%. That is a compound annual growth rate of 16.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 4.19B | -22.98% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 4.65B |
| Sinew Pharma | 4.29B |
| Medigen Biotechnology | 4.28B |
| Sunhawk Vision Biotech | 4.17B |
| BRIM Biotechnology | 3.87B |
| TWi Biotechnology | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.39B |
| Pharmosa Biopharm | 3.28B |